Blandino, A.* et al. Small-RNA sequencing reveals potential serum biomarkers for gallbladder cancer: Results from a three-stage collaborative study of large European prospective cohorts. Eur. J. Cancer 214:115138 (2025)
Holch, J.W.* et al. FOLFIRI with cetuximab or bevacizumab in RAS wild-type metastatic colorectal cancer: Refining first-line treatment selection by combining clinical parameters: A post hoc analysis of the randomized open-label phase III trial FIRE-3/AIO KRK0306. Eur. J. Cancer 220:115388 (2025)
Lombardo, E.* et al. DeepClassPathway: Molecular pathway aware classification using explainable deep learning. Eur. J. Cancer 176, 41-49 (2022)
Issels, R.D.* et al. Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial. Eur. J. Cancer 158, 123-132 (2021)
Benmebarek, M.* et al. Characterization of bispecific antibodies that drive synthetic agonistic receptor - transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models. Eur. J. Cancer 110, S3-S3 (2019)
Freudenreich, M.* et al. Clinical relevance of in vitro generated dendritic cells of leukemic origin to predict response to immunotherapy in patients with AML and MDS. Eur. J. Cancer 110, S29-S29 (2019)
Merle, M.* et al. Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in 'DC-culture-media' shifts the (serum) chemokine-release profile to a more 'inflammatory' (in culture) going along with improved antileukemic T-cell-reactivity. Eur. J. Cancer 110, S24-S24 (2019)
Fröhlich, F. et al. Large-scale modeling of cancer signaling: Mechanistic modeling meets Big Data. Eur. J. Cancer 68, S44-S44 (2016)
Hensel, T.* et al. Inhibition of BET bromodomain proteins and the PI3K pathway in Ewing sarcoma down regulates the specific transcriptional program, inhibits tumorigenicity and increases apoptosis in Ewing sarcoma. Eur. J. Cancer 68, S48-S48 (2016)
Luber, B.* et al. Identification of predictive response and resistance factors to targeted therapy in gastric cancer using a systems medicine approach. Eur. J. Cancer 68, S135-S135 (2016)
Tinhofer, I.* et al. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation. Eur. J. Cancer 57, 78-86 (2016)
Vergalli, J. et al. X-Linked inhibitor of apoptosis protein (XIAP) exhibits an essential role of patients' acute lymphoblastic leukemia cells growing in vivo. Eur. J. Cancer 68, S58-S59 (2016)
von Heyking, K.* et al. The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma. Eur. J. Cancer 68, S47-S47 (2016)
Gimenez-Aznar, I. et al. Fanconi anemia, complementation group A (FancA) overexpression confers radioresistance to oral keratinocytes. Eur. J. Cancer 51, S121 (2015)
Neff, F.* et al. Notch triggers myeloid reprogramming in murine pancreatic cancer. Eur. J. Cancer 51, S2 (2015)
Schnorfeil, F.M. et al. Vaccination with next-generation dendritic cells for aml postremission therapy induces antigen-specific T cell responses. Eur. J. Cancer 51, S8 (2015)
Bauer, J. ; Sandhöfer, N. ; Hiddemann, W. & Spiekermann, K. Novel FLT3 mutation shows dominant negative effects on the wild-type FLT3 receptor. Eur. J. Cancer 50, S121 (2014)
Burton, N.* et al. Real time noninvasive 2D and 3D Multispectral Optoacoustic Tomography (MSOT) for clinical imaging of vessel oxygenation and melanin distribution. Eur. J. Cancer 50, S157 (2014)
Driessen, W.H.P.* et al. Novel approaches for dynamic biomarker imaging by Multispectral Optoacoustic Tomography (MSOT). Eur. J. Cancer 50, S55 (2014)
Gimenez-Aznar, I. et al. FancA overexpression confers radioresistance to cells of head and neck squamous cell carcinoma. Eur. J. Cancer 50, S229 (2014)
Höfig, I. et al. Relevance of 3D-microtissues to investigate the therapeutic oncogenes HER2 and PTK6 in breast cancer. Eur. J. Cancer 50, S226 (2014)
Huber, M. et al. uPAR and its interaction partners: potential new therapy targets in triple negative breast cancer. Eur. J. Cancer 50, S161-S162 (2014)
Lee, M.S. ; Gaertner, F.C.* & Pellegata, N.S. Regulation of norepinephrine transporter expression in pheochromocytoma by dual PI3K/mTOR inhibition. Eur. J. Cancer 50, S154 (2014)
Leinhäuser, I. ; Atkinson, M.J. & Pellegata, N.S. The transcription factor Phox2a plays a pro-tumorigenic role in pheochromocytoma. Eur. J. Cancer 50, S160 (2014)
Martin, A. et al. Cullin-RING ligases inhibition is a potential new therapeutic strategy in soft tissue sarcomas. Eur. J. Cancer 50, S159 (2014)
Michna, A. et al. Identification of molecular targets and signalling networks that influence hypersensitivity to ionizing radiation. Eur. J. Cancer 50, S134 (2014)
Morscher, S.* et al. Pharmacokinetic modelling in Dynamic Contrast Enhanced Multispectral Optoacoustic Tomography (DCE-MSOT). Eur. J. Cancer 50, S160-S161 (2014)
Pastula, A.* ; Hauck, S.M. ; Janssen, K.P.* ; Schmid, R.M.* & Quante, M.* Mesenchymal cells regulate growth of intestinal crypts by a Wnt independent mechanism in 3D culture system. Eur. J. Cancer 50, S63 (2014)
Pellegata, N.S. et al. p27 is a haploinsufficient tumor suppressor in MENX rats and this associates with the development of invasive medullary thyroid carcinoma. Eur. J. Cancer 50, S57 (2014)
Selmansberger, M. et al. CLIP2 as radiation biomarker in papillary thyroid carcinoma. Eur. J. Cancer 50, S113 (2014)
Simonavicius, N. et al. Lymphotoxin signalling alters the vasculature to increase tumour cell metastasis. Eur. J. Cancer 50, S88 (2014)
Weller, P.* et al. The role of tumour FoxP3 as prognostic marker in different subtypes of head and neck cancer. Eur. J. Cancer 50, 1291-1300 (2014)
Wilke, C. et al. Comparative global characterisation of microRNA-expression in radiation-associated and sporadic breast carcinomas. Eur. J. Cancer 50, S229 (2014)
Cote, M.L.* et al. Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium. Eur. J. Cancer 48, 1957-1968 (2012)
Frank, B.* et al. Polymorphisms in MUC1, MUC2, MUC5B and MUC6 genes are not associated with the risk of chronic atrophic gastritis. Eur. J. Cancer 48, 114-120 (2012)
Mutze, K.* et al. DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer. Eur. J. Cancer 47, 1817-1825 (2011)
Ebelt, K. et al. Prostate cancer lesions are surrounded by FOXP3⁺, PD-1⁺ and B7-H1⁺ lymphocyte clusters. Eur. J. Cancer 45, 1664-1672 (2009)
Issels, R.D. Hyperthermia adds to chemotherapy. Eur. J. Cancer 44, 2546-2554 (2008)
Schaefer, K.L.* et al. Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy. Eur. J. Cancer 44, 699-709 (2008)
Verweij, J.* et al. Imatinib does not induce cardiac left ventricular failure in gastrointestinal stromal tumours patients: Analyis of EORTC-ISG-AGITG study 62005. Eur. J. Cancer 43, 974-978 (2007)
Debiec-Rychter, M.* et al. KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. Eur. J. Cancer 42, 1093-1103 (2006)
Rashid, M.U.* & Wichmann, H.-E. German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer. Eur. J. Cancer 41, 2896-2903 (2005)
Zalcberg, J.R.* et al. Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose 800 mg after progression on 400 mg. Eur. J. Cancer 41, 1751-1757 (2005)
Ensoli, B.* et al. Biology of Kaposi's sarcoma. Eur. J. Cancer 37, 1251-1269 (2001)
Issels, R.D. et al. Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults : Long-term results of a phase II study. Eur. J. Cancer 37, 1599-1608 (2001)
Wendtner, C.-M. et al. Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults : Results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia. Eur. J. Cancer 37, 1609-1616 (2001)
Wollenberg, B. et al. Pilotstudy with a trifunctional bispecific antibody in patients with Head and Neck Cancer. Eur. J. Cancer 1, S61 (2001)
Lau, B. ; Janka, G.E.* ; Meister, P.* ; Lampert, F.H.* & Haas, R.J.* Childhood malignant lymphoma. Favourable outlook with aggressive combination chemotherapy and radiotherapy. Eur. J. Cancer 13, 1237-1240 (1977)